Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.24.1.1.u2
CONDENSED BALANCE SHEETS - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 56,435 $ 200,059
Prepaid expenses 107,990 62,174
Cash and marketable securities held in Trust Account 17,335,558 16,978,160
Total Current Assets 17,499,983 17,240,393
Total Assets 17,499,983 17,240,393
Current liabilities    
Accrued expenses 1,146,084 1,099,863
Promissory note - related party 864,930 416,841
Excise taxes payable 1,029,003 1,029,003
Income taxes payable 28,977 142,500
Total Current Liabilities 3,068,994 2,688,207
Commitments and Contingencies
Common stock subject to possible redemption, $0.0001 par value; 1,582,797 shares at $10.91 per share and $10.71 per share redemption value as of March 31, 2024 and December 31, 2023, respectively 17,269,523 16,949,887
Stockholders' Deficit    
Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,336,500 shares issued and outstanding (excluding 1,582,797 shares subject to possible redemption) as of March 31, 2024 and December 31, 2023, respectively 334 334
Accumulated deficit (2,838,868) (2,398,035)
Total Stockholders' Deficit (2,838,534) (2,397,701)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 17,499,983 $ 17,240,393